Bank of Nova Scotia’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,104,245
| Closed | -$203M | – | 1166 |
|
|
2021
Q2 | $203M | Buy |
1,104,245
+31,666
| +3% | +$5.82M | 0.37% | 61 |
|
|
2021
Q1 | $164M | Buy |
1,072,579
+1,031,241
| +2,495% | +$158M | 0.32% | 73 |
|
|
2020
Q4 | $6.46M | Buy |
41,338
+8,118
| +24% | +$1.27M | 0.01% | 428 |
|
|
2020
Q3 | $3.8M | Buy |
+33,220
| New | +$3.8M | 0.01% | 480 |
|
|
2020
Q2 | – | Sell |
-192,524
| Closed | -$17.3M | – | 1061 |
|
|
2020
Q1 | $17.3M | Sell |
192,524
-41,952
| -18% | -$3.77M | 0.06% | 234 |
|
|
2019
Q4 | $25.4M | Buy |
234,476
+189,497
| +421% | +$20.5M | 0.06% | 243 |
|
|
2019
Q3 | $4.41M | Buy |
44,979
+1,995
| +5% | +$195K | 0.01% | 506 |
|
|
2019
Q2 | $5.63M | Buy |
42,984
+394
| +0.9% | +$51.6K | 0.02% | 395 |
|
|
2019
Q1 | $5.76M | Sell |
42,590
-5,017
| -11% | -$678K | 0.02% | 405 |
|
|
2018
Q4 | $4.64M | Buy |
47,607
+2,321
| +5% | +$226K | 0.02% | 413 |
|
|
2018
Q3 | $6.29M | Buy |
45,286
+20,851
| +85% | +$2.9M | 0.03% | 378 |
|
|
2018
Q2 | $3.03M | Sell |
24,435
-3,782
| -13% | -$469K | 0.02% | 413 |
|
|
2018
Q1 | $3.14M | Sell |
28,217
-209,793
| -88% | -$23.4M | 0.02% | 458 |
|
|
2017
Q4 | $28.5M | Buy |
238,010
+199,242
| +514% | +$23.8M | 0.13% | 161 |
|
|
2017
Q3 | $5.44M | Sell |
38,768
-11,986
| -24% | -$1.68M | 0.03% | 351 |
|
|
2017
Q2 | $6.18M | Sell |
50,754
-676
| -1% | -$82.2K | 0.03% | 386 |
|
|
2017
Q1 | $6.24M | Buy |
51,430
+46,404
| +923% | +$5.63M | 0.03% | 361 |
|
|
2016
Q4 | $615K | Sell |
5,026
-23,530
| -82% | -$2.88M | ﹤0.01% | 527 |
|
|
2016
Q3 | $3.5M | Buy |
28,556
+6,060
| +27% | +$743K | 0.02% | 250 |
|
|
2016
Q2 | $2.63M | Buy |
22,496
+18,280
| +434% | +$2.13M | 0.02% | 247 |
|
|
2016
Q1 | $587K | Buy |
4,216
+20
| +0.5% | +$2.79K | ﹤0.01% | 414 |
|
|
2015
Q4 | $800K | Sell |
4,196
-40
| -0.9% | -$7.63K | ﹤0.01% | 384 |
|
|
2015
Q3 | $662K | Buy |
4,236
+630
| +17% | +$98.5K | ﹤0.01% | 340 |
|
|
2015
Q2 | $652K | Buy |
3,606
+94
| +3% | +$17K | ﹤0.01% | 326 |
|
|
2015
Q1 | $609K | Buy |
3,512
+142
| +4% | +$24.6K | ﹤0.01% | 331 |
|
|
2014
Q4 | $624K | Buy |
3,370
+160
| +5% | +$29.6K | ﹤0.01% | 329 |
|
|
2014
Q3 | $532K | Buy |
3,210
+102
| +3% | +$16.9K | ﹤0.01% | 351 |
|
|
2014
Q2 | $486K | Buy |
3,108
+167
| +6% | +$26.1K | ﹤0.01% | 363 |
|
|
2014
Q1 | $447K | Buy |
2,941
+261
| +10% | +$39.7K | ﹤0.01% | 400 |
|
|
2013
Q4 | $357K | Buy |
2,680
+230
| +9% | +$30.6K | ﹤0.01% | 427 |
|
|
2013
Q3 | $285K | Sell |
2,450
-249
| -9% | -$29K | ﹤0.01% | 428 |
|
|
2013
Q2 | $249K | Buy |
+2,699
| New | +$249K | ﹤0.01% | 426 |
|